Literature DB >> 33467499

High Expression Level of PPARγ in CD24 Knockout Mice and Gender-Specific Metabolic Changes: A Model of Insulin-Sensitive Obesity.

Shiran Shapira1,2, Dina Kazanov1, Rachel Dankner3,4, Sigal Fishman5, Naftali Stern6, Nadir Arber1,2,5.   

Abstract

BACKGROUND: The heat-stable HSA/CD24 gene encodes a protein that shows high expression levels in adipocyte precursor cells but low levels in terminally differentiated adipocytes. Its high expression in many types of human cancer suggests an association between cancer, diabetes, and obesity, which is currently unclear. In addition, peroxisome proliferator-activated receptor gamma (PPARγ) is a regulator of adipogenesis that plays a role in insulin sensitivity, lipid metabolism, and adipokine expression in adipocytes. AIM: To assess gender-dependent changes in CD24 KO and its association with PPARγ expression. EXPERIMENTAL APPROACH: WT and CD24 KO mice were monitored from birth up to 12 months, and various physiological and molecular characteristics were analysed. Mean body weight and adipose mass were higher in KO mice than in WT mice. Male, but not female, KO mice showed increased insulin sensitivity, glucose uptake, adipocyte size, and PPARγ expression than WT mice. In addition, enteric bacterial populations, assessed through high-throughput sequencing of stool 16S rRNA genes, were significantly different between male KO and WT mice.
CONCLUSIONS: CD24 may negatively regulate PPARγ expression in male mice. Furthermore, the association between the CD24 and insulin sensitivity suggests a possible mechanism for diabetes as a cancer risk factor. Finally, CD24 KO male mice may serve as a model of obesity and insulin hyper-sensitivity.

Entities:  

Keywords:  CD24; PPARγ; cancer; diabetes; insulin sensitivity

Year:  2021        PMID: 33467499      PMCID: PMC7829882          DOI: 10.3390/jpm11010050

Source DB:  PubMed          Journal:  J Pers Med        ISSN: 2075-4426


  71 in total

Review 1.  Diabetes and cancer (1): evaluating the temporal relationship between type 2 diabetes and cancer incidence.

Authors:  J A Johnson; B Carstensen; D Witte; S L Bowker; L Lipscombe; A G Renehan
Journal:  Diabetologia       Date:  2012-04-04       Impact factor: 10.122

2.  Insulin-sensitive obesity.

Authors:  Nora Klöting; Mathias Fasshauer; Arne Dietrich; Peter Kovacs; Michael R Schön; Matthias Kern; Michael Stumvoll; Matthias Blüher
Journal:  Am J Physiol Endocrinol Metab       Date:  2010-06-22       Impact factor: 4.310

Review 3.  Physical inactivity and obesity: links with insulin resistance and type 2 diabetes mellitus.

Authors:  Michelle C Venables; Asker E Jeukendrup
Journal:  Diabetes Metab Res Rev       Date:  2009-09       Impact factor: 4.876

4.  Downregulation of CD24 inhibits invasive growth, facilitates apoptosis and enhances chemosensitivity in gastric cancer AGS cells.

Authors:  X-L Jiao; C Zhao; M Niu; D Chen
Journal:  Eur Rev Med Pharmacol Sci       Date:  2013-07       Impact factor: 3.507

5.  Abdominal adiposity and insulin resistance in obese men.

Authors:  Robert Ross; James Aru; Jennifer Freeman; Robert Hudson; Ian Janssen
Journal:  Am J Physiol Endocrinol Metab       Date:  2002-03       Impact factor: 4.310

6.  CD24 expression predicts distant metastasis in extrahepatic bile duct cancer.

Authors:  Kyubo Kim; Hye Sook Min; Eui Kyu Chie; Jin-Young Jang; Sun Whe Kim; Sae-Won Han; Do-Youn Oh; Seock-Ah Im; Tae-You Kim; Yung-Jue Bang; Ja-June Jang; Sung W Ha
Journal:  World J Gastroenterol       Date:  2013-03-07       Impact factor: 5.742

7.  Differentiation of CD24- pancreatic ductal cell-derived cells into insulin-secreting cells.

Authors:  Chun-You Wang; Shan-Miao Gou; Tao Liu; He-Shui Wu; Jiong-Xin Xiong; Feng Zhou; Jing Tao
Journal:  Dev Growth Differ       Date:  2008-07-21       Impact factor: 2.053

8.  Relation of body fat distribution to metabolic complications of obesity.

Authors:  A H Kissebah; N Vydelingum; R Murray; D J Evans; A J Hartz; R K Kalkhoff; P W Adams
Journal:  J Clin Endocrinol Metab       Date:  1982-02       Impact factor: 5.958

9.  The PPARG Pro12Ala polymorphism is associated with a decreased risk of developing hyperglycemia over 6 years and combines with the effect of the APM1 G-11391A single nucleotide polymorphism: the Data From an Epidemiological Study on the Insulin Resistance Syndrome (DESIR) study.

Authors:  Riphed Jaziri; Stephane Lobbens; Roberte Aubert; Franck Péan; Saida Lahmidi; Martine Vaxillaire; Isabelle Porchay; Naïma Bellili; Jean Tichet; Beverley Balkau; Philippe Froguel; Michel Marre; Frédéric Fumeron
Journal:  Diabetes       Date:  2006-04       Impact factor: 9.461

10.  Sex differences in human adipose tissue gene expression and genetic regulation involve adipogenesis.

Authors:  Warren D Anderson; Joon Yuhl Soh; Sarah E Innis; Alexis Dimanche; Lijiang Ma; Carl D Langefeld; Mary E Comeau; Swapan K Das; Eric E Schadt; Johan L M Björkegren; Mete Civelek
Journal:  Genome Res       Date:  2020-09-23       Impact factor: 9.043

View more
  1 in total

1.  CD24-Siglec axis is an innate immune checkpoint against metaflammation and metabolic disorder.

Authors:  Xu Wang; Mingyue Liu; Jifeng Zhang; Nicholas K Brown; Peng Zhang; Yan Zhang; Heng Liu; Xuexiang Du; Wei Wu; Martin Devenport; Weng Tao; Yang Mao-Draayer; Guo-Yun Chen; Y Eugene Chen; Pan Zheng; Yang Liu
Journal:  Cell Metab       Date:  2022-08-02       Impact factor: 31.373

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.